SEC Filing Summary: Neuralstem, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuralstem, Inc. on December 18, 2008, reporting events occurring on December 17, 2008. The filing details the closing of a private placement offering of common stock pursuant to a previously effective Form S-3 Registration Statement.
Key Financial Metrics
- Gross Proceeds: $2.0 million from the sale of 1,600,000 shares at $1.25 per share.
- Net Proceeds: Approximately $1.760 million after deducting placement agent fees and offering expenses.
- Placement Agent Compensation: $140,000 cash fee (7% of gross proceeds) plus a warrant to purchase 112,000 shares.
- Warrant Terms: The Placement Agent Warrant is exercisable for five years at an exercise price of $1.50 per share (120% of the purchase price).
- Revenue, Profit, and Debt: The filing text does not provide a clear value for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes and Agreements
The primary material change is the entry into a Material Definitive Agreement (Securities Purchase Agreement) with certain investors. Key contractual obligations include:
- Reporting Penalty: If the Company fails to remain current in its reporting requirements for any 30-day period within 360 days of closing, it must pay investors 10% of the shares held by them.
- Right of First Refusal: For six months following the closing, the Company cannot issue common stock or equivalents without first offering them to the Purchasers on the same terms as any third party.
- Short Sale Restriction: Purchasers warranted they did not execute short sales in the Company's securities through the closing date.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of general business risks. The primary contingency identified is the potential dilution obligation to investors if the Company fails to maintain current reporting status with the SEC within the next year.
Investor Verification Checklist
- Verify the Company's current status regarding SEC reporting requirements to assess the risk of the 10% share penalty.
- Confirm the total number of outstanding shares post-offering to calculate the dilution impact of the 1,600,000 new shares and the 112,000 warrant shares.
- Review the full Securities Purchase Agreement (Exhibit 10.1) for additional covenants not summarized in the 8-K.
- Check subsequent filings for the use of the $1.760 million in net proceeds.